Scioto Biosciences
Indianapolis
About Scioto Biosciences
Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2020)
- Website: sciotobiosciences.com
- Phone: +1 866 672 4686
Industries & Categories
Biotechnology, Diabetes, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/scioto-biosciences-86994 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.